@FierceMedDev: BioFire Diagnostics pulls in $25M in new funding for accelerated product development. Release | Follow @FierceMedDev
@MarkHFierce: The iPhone 5 could accelerate the migration of medical devices to Bluetooth, eWeek reports. More | Follow @MarkHFierce
@DamianFierce: Medtronic is looking to pair its pump technology with the next generation of Alzheimer's drugs. Report | Follow @DamianFierce
> Covidien ($COV) has launched the Viance crossing catheter and Enteer re-entry system, designed to treat chronic total occlusions endovascularly, in the U.S. and EU. More
> Meridian Bioscience ($VIVO) got FDA approval for its new molecular diagnostic test for Group A strep throat. Item
> Sequenom ($SQNM) raised $130 million through the sale of senior notes, money the company will use to market its MaterniT21 Plus pre-natal test. Story
> AtriCure has treated its first patient with its new atrial fibrillation device, the first part of an FDA-approved pilot study. Release
> Codman & Shutleff is touting positive data for its vascular reconstruction device, a self-expanding stent designed to treat patients with wide neck saccular aneurysms. Article
> Fortune has a blow-by-blow account of Synthes' illegal tests of its bone cement. News
> Malaysia's Medical Device Authority is reforming its regulatory policies, seeking public comment on proposed new rules for devicemakers there. Report
> DFine has launched its Star tumor ablation system in the U.S. Release
> Canadian cancer diagnostics company Mitomics says it has a bright future, despite recent job cuts. More
Biotech News
@FierceBiotech: Bedside blood infection test being developed for sepsis. Item | Follow @FierceBiotech
@JohnCFierce: Interesting: J&J setting up 4 deal teams around the globe - Boston. California. China and London. Via Reuters: Report | Follow @JohnCFierce
@RyanMFierce: Fierce 15 arrives tomorrow. Here are some details on what to expect: More | Follow @RyanMFierce
> Medtronic dangles Alzheimer's delivery tech to frustrated pharmas. Story
> Software mogul commits $104M to CureVac's cancer vax work. More
Pharma News
@FiercePharma: WSJ's story on the Chinese drug-price cuts: Report | Follow @FiercePharma
> Analysts eye generic threat as Vivus rolls out Qsymia. Article
> Merck yanks European app for Erbitux in lung cancer. Story
> Costly cancer drugs get the Chinese price-cutting treatment. More
Pharma Manufacturing News
> Gelatin prices look to rise steeply. Story
> Boehringer Ingelheim closing 1 of 3 U.S. API plants. More
> India says it will meet EU's API quality deadline. Report
Biotech Research News
> Mayo Clinic spies enzyme that destroys brain-clogging Alzheimer's protein. More
> Drug combo packs punch fighting rare form of melanoma in mice. Story
> UMass sensor array 'smelled' metastatic cancer cells in preclinical study. Article